From the National Alzheimer's Coordinating Center, Department of Epidemiology, University of Washington, Seattle, Washington, USA (MAT, CM, KG, JEC, Y-CC, KCGC, WAK); Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA (GJ, PTN, YK); Division of Neuropathology, Department of Pathology, University of Kentucky, Lexington, Kentucky, USA (PTN); Department of Biostatistics, University of Kentucky, Lexington, Kentucky, USA (YK).
J Neuropathol Exp Neurol. 2021 Nov 19;80(11):1024–1032. doi: 10.1093/jnen/nlab098. Epub 2021 Oct 1.
Transactive response DNA-binding protein 43 kDa (TDP-43) is aberrantly aggregated and phosphorylated in frontotemporal lobar degeneration of the TDP-43 type (FTLD-TDP), and in limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC). We examined data from the National Alzheimer's Coordinating Center to compare clinical features of autopsy-confirmed LATE-NC and FTLD-TDP. A total of 265 LATE-NC and 92 FTLD-TDP participants were included. Cognitive and behavioral symptoms were compared, stratified by level of impairment based on global clinical dementia rating (CDR) score. LATE-NC participants were older at death, more likely to carry APOE ε4, more likely to have Alzheimer disease neuropathology, and had lower (i.e. less severe) final CDR global scores than those with FTLD-TDP. Participants with FTLD-TDP were more likely to present with primary progressive aphasia, or behavior problems such as apathy, disinhibition, and personality changes. Among participants with final CDR score of 2-3, those with LATE-NC were more likely to have visuospatial impairment, delusions, and/or visual hallucinations. These differences were robust after sensitivity analyses excluding older (≥80 years at death), LATE-NC stage 3, or severe Alzheimer cases. Overall, FTLD-TDP was more globally severe, and affected younger participants, whereas psychoses were more common in LATE-NC.
转激活反应 DNA 结合蛋白 43kDa(TDP-43)在 TDP-43 型额颞叶变性(FTLD-TDP)和边缘优势型与年龄相关的 TDP-43 脑病神经病理改变(LATE-NC)中异常聚集和磷酸化。我们检查了国家阿尔茨海默病协调中心的数据,以比较尸检证实的 LATE-NC 和 FTLD-TDP 的临床特征。共纳入 265 例 LATE-NC 和 92 例 FTLD-TDP 参与者。根据全球临床痴呆评定量表(CDR)评分,根据认知和行为症状的损害程度进行分层,比较认知和行为症状。LATE-NC 参与者死亡时年龄较大,携带 APOE ε4 的可能性更高,更有可能患有阿尔茨海默病病理学,且最终 CDR 全球评分较低(即较轻),与 FTLD-TDP 患者相比。FTLD-TDP 参与者更可能出现原发性进行性失语,或出现冷漠、抑制障碍和人格改变等行为问题。在最终 CDR 评分为 2-3 的参与者中,LATE-NC 参与者更可能出现视觉空间障碍、妄想和/或幻视。在排除年龄较大(死亡时≥80 岁)、LATE-NC 第 3 阶段或严重阿尔茨海默病病例的敏感性分析后,这些差异仍然存在。总的来说,FTLD-TDP 更为全身性严重,影响年轻参与者,而精神病在 LATE-NC 中更为常见。